← All diseases Cancer

Prostate cancer (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (137)Meta-analysis (28)Treatment guideline (1)Randomized trial (67)Phase 3 study (21)Systematic review (20)Clinical trial (627)Review article (238)Early study (phase 1 or 2) (44)Single patient description (132)Laboratory or animal study (27)Commentary or editorial (29)Retracted publication (3) Studies currently recruiting participants only (49)

Filter

Publications and studies (2075)

• The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence. (2022/12/30) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. (2022/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients. (2022/12/30) ♡
• Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study. (2022/12/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer. (2022/12/29) ♡
• Obesity in the Pediatric Population of the National (Nationwide) Inpatient Sample (NIS), USA. (2022/12/29) ♡
• Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort. (2022/12/28) ♡
• Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth. (2022/12/27) ♡
• Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance. (2022/12/27) ♡
• A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression. (2022/12/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elevated IOP following a bladder filling protocol: A case report. (2022/12/23) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer. (2022/12/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer. (2022/12/22) ♡
• Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. (2022/12/22) ♡
• Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells. (2022/12/22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial. (2022/12/21) ♡
• Detection of Circulating Tumor Cells Using the Attune NxT. (2022/12/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies. (2022/12/16) ♡
• Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer. (2022/12/15) ♡
• Comparison of PSMA-based (18)F-DCFPyL PET/CT and pelvic multiparametric MRI for lesion detection in the pelvis in patients with prostate cancer. (2022/12/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley's Toxin Revisited? (2022/12/14) ♡
• Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres. (2022/12/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic prostate cancer with low PSA levels diagnosed after holmium laser enucleation of the prostate. (2022/12/02) ♡
• Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy. (2022/12/01) ♡
• DDR genes analysis and PARP-inhibitors therapy as tailored management in metastatic prostate cancer: achieved answers, open questions and future perspectives. (2022/12/01) ♡
• The current evidence on prognostic factors in metastatic castration-resistant prostate cancer patients treated with Radium-223. (2022/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Assessment of real-world application of advanced prostate cancer management in Japan. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference. (2022/12/01) ♡
• A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma. (2022/12/01) ♡
• How has the COVID-19 pandemic influenced prostate cancer?-a tertiary single-centre analysis of oncological results, diagnosis and treatment times. (2022/12/01) ♡
• Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer? (2022/12/01) ♡
• 2022 UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer Full-text. (2022/12/01) ♡
• 2022 UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer Summary of changes. (2022/12/01) ♡
• Treatment Patterns Among Patients With Advanced Prostate Cancer in Brazil: An Analysis of a Private Healthcare System Database. (2022/12/01) ♡
• Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature. (2022/12/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Pitfall of the Androgen Deprivation Therapy for Salivary Duct Carcinoma: Hormonal Therapy-Induced Castrate-Resistant Prostate Cancer. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour. (2022/11/16) ♡
• Disability weights for castration-resistant prostate cancer: an empirical investigation. (2022/11/14) ♡
• Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance]). (2022/11/01) ♡
• Paradoxical Radiosensitizing Effect of Carnosic Acid on B16F10 Metastatic Melanoma Cells: A New Treatment Strategy. (2022/10/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? (2022/10/28) ♡
• Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients. (2022/10/26) ♡
• Definitions of "Cure" After Low-Dose-Rate Brachytherapy in Low- and Intermediate-Risk Prostate Cancer: Phoenix or Surgical? (2022/10/21) ♡
• Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer. (2022/10/20) ♡
• Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy. (2022/10/01) ♡
• Solitary Penile Metastasis from Prostate Cancer on (18)F-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. GENOMICS OF PROSTATE CANCER: CLINICAL UTILITY AND CHALLENGES. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HOW TO OPTIMALLY SEQUENCE AVAILABLE THERAPY LINES IN ADVANCED PROSTATE CANCER. (2022/10/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.